For its first fiscal quarter (ending March 31), Surgery Partners Inc (NASDAQ: SGRY) has reported E.P.S. of $-0.10 compared to $-0.20 a year ago. This performance was $-0.26 short of the consensus estimate of $0.16. E.P.S. were $0.00 for the latest four quarters through March 31 versus $-0.92 for the same period a year ago.
Recent Price Action
Surgery Partners Inc (NASDAQ: SGRY) stock closed at $27.77 on 5/7/24 after a very large increase of 8.5%. Moreover, this advance was accompanied by exceptionally high trading volume at 339% of normal. The stock has risen 12.2% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, SGRY is expected to continue to be a modest Value Builder.
Surgery Partners has a current Value Trend Rating of C (Neutral). This rating combines contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Surgery Partners has a slightly positive Appreciation Score of 64 but a slightly negative Power Rating of 38, with the Neutral Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment